Table 2.
PVN (nCi/g) | BNST (nCi/g) | BLA (nCi/g) | CeA (nCi/g) | Cingulate (nCi/g) | Septum (nCi/g) | dHipp (nCi/g) | |
---|---|---|---|---|---|---|---|
SHAM | 0.31 ± 0.01 | 0.35 ± 0.02 | 0.42 ± 0.02 | 0.13 ± 0.01 | 0.12 ± 0.01 | 0.43 ± 0.03 | 0.12 ± 0.01 |
CA/CPR (7d) | 0.27 ± 0.02* | 0.33 ± 0.02 | 0.34 ± 0.02* | 0.10 ± 0.01* | 0.12 ± 0.01 | 0.42 ± 0.03 | 0.10 ± 0.01* |
CA/CPR (21d) | 0.37 ± 0.03* | 0.37 ± 0.02 | 0.42 ± 0.02 | 0.12 ± 0.01 | 0.11 ± 0.02 | 0.40 ± 0.03 | 0.14 ± 0.02 |
CRF2Areceptor binding for multiple brain regions after SHAM surgery, 7d of recovery from cardiac arrest and cardiopulmonary resuscitation (CA/CPR) surgery, or 21d recovery from CA/CPR surgery.
Values are expressed as mean ± s.e.m. and *indicates P < 0.05 when compared with the SHAM group.
Samples were timepoints.
PVN, paraventricular nucleus of the hypothalamus; BNST, basal nucleus of the stria terminalis; BLA, basolateral nucleus of the amygdala; CeA, central nucleus of the amygdala; cingulate, cingulate cortex; CRF, corticotropin releasing factor; dHipp, dorsal hippocampus.